# Code Biotherapeutics funding: rounds and investors

> Code Biotherapeutics has raised $75M across 1 round since 2022. Investors include New Enterprise Associates, Hatteras Venture Partners and Northpond Ventures.

Source: https://millionrounds.com/company/code-biotherapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Series A startup](https://millionrounds.com/companies)

# Who invested in *Code Biotherapeutics*

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summary Updated 26 Oct 2026

**$75M** raised across 1 round since 2022, from 1 source

- **Latest round:** Series A, $75M Jun 2022
- **Investors:** 3

See who backed them

## The rounds

- **Jun 2022** Series A **$75M** [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [Hatteras Venture Partners](https://millionrounds.com/fund/hatteras-venture-partners) [Northpond Ventures](https://millionrounds.com/fund/northpond-ventures) Source recorded SEC filing: $37M sold, first sale May 2022

## Founders and team

From the SEC filings it signed: 5 on the team.

- **Brian McVeigh** Executive Officer, Director i
- **Erin C Brubaker** Executive Officer i
- **Lauren C Kaskiel** Executive Officer i
- **Robert C Getts** Executive Officer i
- **Russ Fein** Executive Officer, Director i

On the board, as filed i *Dmitry Kuzmin* *Edward Mathers* *Joseph Truitt* *Kathy Rouan* *Robert Lin* *Victor Stone*

## Everyone who backed them

[New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) VC firm **1** round

[Hatteras Venture Partners](https://millionrounds.com/fund/hatteras-venture-partners) VC firm **1** round

[Northpond Ventures](https://millionrounds.com/fund/northpond-ventures) Private equity **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=code-biotherapeutics).

## Quick answers about Code Biotherapeutics

### Who invested in Code Biotherapeutics?

Code Biotherapeutics's investors include New Enterprise Associates, Hatteras Venture Partners and Northpond Ventures.

### How much has Code Biotherapeutics raised?

Code Biotherapeutics has raised $75M across 1 round since 2022.

### When did Code Biotherapeutics last raise?

Code Biotherapeutics's most recent round was a Series A of $75M in Jun 2022.

### What was Code Biotherapeutics's biggest round?

Its most recent round, $75M in Jun 2022, is also its largest on record.

### Who backed Code Biotherapeutics first?

Code Biotherapeutics's first round on record, in Jun 2022, was backed by New Enterprise Associates, Hatteras Venture Partners and Northpond Ventures.

### What stage is Code Biotherapeutics at?

Code Biotherapeutics's latest named round is a Series A, in Jun 2022.

### Where is Code Biotherapeutics based?

Code Biotherapeutics is based in the United States.

## Companies like Code Biotherapeutics

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)[**Clinical Ink** $24M · Oct 2026](https://millionrounds.com/company/clinical-ink)[**Rejuvenate Bio** $13M · Oct 2026](https://millionrounds.com/company/rejuvenate-bio)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app